Crimean–Congo hemorrhagic fever (CCHF) is a dangerous viral illness spread by ticks and livestock; it can cause sudden fever, organ failure and internal bleeding, and there are no approved vaccines or specific treatments. A new mouse study published in npj Vaccines reports promising results for an experimental vaccine developed by a team that includes Scott Pegan at the University of California, Riverside.
The vaccine uses a virus-like replicon particle. It mimics how a virus enters cells but lacks the genetic material needed to replicate, so it cannot cause infection. The team previously showed one dose could protect animals within three days. The new study measured antibody responses after one or two doses and found antibodies detectable for up to 18 months, an interval the authors say roughly equals several human years. Antibody levels were similar between one- and two-dose groups for about nine months; a booster produced stronger, more stable antibodies and longer protection.
The vaccine focuses on internal viral proteins, especially the N protein, normally hidden inside the virus and important for immunity. Researchers aim to move to large-scale production under Good Manufacturing Practice before human trials. Partners at the CDC are already exploring the platform for other pathogens.
Difficult words
- hemorrhagic — causing severe bleeding inside the body
- replicon — a viral particle that cannot make full copies
- antibody — a blood protein that fights infectionsantibodies
- booster — an extra vaccine dose to increase protection
- platform — a system or method used for development
- pathogen — an organism that causes disease in peoplepathogens
- replicate — to make more copies of itself
- immunity — protection in the body against disease
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why might it be important that the vaccine cannot replicate in the body?
- Would you feel more confident about a vaccine that gives detectable antibodies for 18 months? Why or why not?
- How could using the same vaccine platform for different pathogens help public health?
Related articles
Wheat fiber protects mice from intestinal inflammation
Two research papers report that adding wheat fiber to the diet protects mice from intestinal inflammation. Gut bacteria release polyphenols from the fiber that reduce inflammation, and authors suggest whole-grain foods may lower IBD risk.
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
Milk glands in many mammals have receptors for H5N1
A study found that milk gland tissue from pigs, sheep, goats, beef cattle, alpacas and humans contains sialic acid receptors that can let H5N1 attach to cells. Researchers warn of surveillance and concerns about raw milk from mammals.
Worry about police linked to heart risk in Black women
A US study of 422 Black women found that worry about police interactions—especially concern for their children—was associated with thicker carotid artery measurements, a marker of cardiovascular risk. The study shows correlation, not causation.